Treatment Outcome in Patients with <i>Mycobacterium abscessus</i> Complex Lung Disease: The Impact of Tigecycline and Amikacin
Background: The contemporary guidelines have recommended multiple antimicrobial therapies along with oral macrolides for the treatment of <i>Mycobacterium abscessus</i> complex lung disease (MABC-LD). However, there is little evidence supporting the parenteral tigecycline-containing regi...
Saved in:
Main Authors: | Jeng-How Yang (Author), Ping-Huai Wang (Author), Sheng-Wei Pan (Author), Yu-Feng Wei (Author), Chung-Yu Chen (Author), Ho-Sheng Lee (Author), Chin-Chung Shu (Author), Ting-Shu Wu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic Determinants of Tigecycline Resistance in <i>Mycobacteroides abscessus</i>
by: Hien Fuh Ng, et al.
Published: (2022) -
Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus
by: Hien Fuh Ng, et al.
Published: (2020) -
The Contribution of Efflux Pumps in <i>Mycobacterium abscessus</i> Complex Resistance to Clarithromycin
by: Júlia S. Vianna, et al.
Published: (2019) -
Alternatives to Antibiotics against <i>Mycobacterium abscessus</i>
by: Antonio Broncano-Lavado, et al.
Published: (2022) -
Antimicrobial and Antibiofilm Effects of Bithionol against <i>Mycobacterium abscessus</i>
by: Dan Cao, et al.
Published: (2024)